AMN Healthcare Services vs Robert Half
AMN and RHI side by side, both in personnel supply services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMN and RHI compare
Robert Half is the larger company, worth 2.9 times as much as AMN Healthcare Services ($4.3B against $1.5B).
On earnings, AMN Healthcare Services is cheaper: it trades at 13.8× trailing earnings, against 34.9× for Robert Half.
AMN Healthcare Services grew revenue faster over the last twelve months (29.5% versus −2.9% for Robert Half).
AMN Healthcare Services keeps more of each dollar of sales as profit, with a net margin of 3.1% compared with 2.3% at Robert Half.
Robert Half pays a dividend yielding 5.6%; AMN Healthcare Services does not pay one.
AMN Healthcare Services scores higher on the StockData Score (14 against 12 for Robert Half), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMN | RHI |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $4.3B |
| Share price | $37.90 | $42.22 |
| Change, 1 year | 118% | 63.3% |
| Change, 5 years | −68.0% | −64.1% |
| Beta (5Y) | 0.72 | 0.94 |
| Employees | 2,664 | 7,100 |
| StockData Score | ||
| Total score | 14 (better) | 12 |
| Valuation score | 5 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 3 (better) | 2 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 13.8× (better) | 34.9× |
| P/S | 0.4× (better) | 0.8× |
| P/B | 1.9× (better) | 3.6× |
| EV/EBITDA | 5.8× (better) | 55.6× |
| P/FCF | 4.5× (better) | 20.7× |
| FCF yield | 22.3% (better) | 4.8% |
| Fair value | $55.46 | $24.54 |
| Margin of safety | 31.7% (better) | −72.0% |
| Growth | ||
| Revenue growth (TTM) | 29.5% (better) | −2.9% |
| Revenue growth, 5Y average | 2.7% (better) | 1.0% |
| Net income growth (TTM) | – | −21.7% |
| EPS growth (TTM) | – | −21.4% |
| EPS growth, 5Y average | – | −13.2% |
| Profitability | ||
| Gross margin | 28.4% | 37.3% (better) |
| Operating margin | 5.8% (better) | 1.4% |
| Net margin | 3.1% (better) | 2.3% |
| FCF margin | 9.3% (better) | 3.9% |
| Return on equity | 15.4% (better) | 9.8% |
| Return on invested capital | 9.8% (better) | 5.0% |
| Financial health | ||
| Debt / equity | 0.96 (better) | 0.00 |
| Net debt / EBITDA | 1.45 | – |
| Interest coverage | 6.1× | – |
| Current ratio | 1.21 | 1.48 (better) |
| Altman Z-score | 3.29 | 3.81 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 5.6% |
| Payout ratio | – | 196% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 11.7% |
| Buyback yield | – | 0.16% |
| Shareholder yield | 0.00% | 5.7% (better) |
| Ownership | ||
| Held by institutions | 120% | 124% |
| Held by insiders | 0.87% | 3.7% |
| Insider net buying, 12 months | −$114K | $0 (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 11.1% | 19.3% |
Go deeper
- AMN stock overview
- AMN income statement
- AMN valuation and score
- RHI stock overview
- RHI income statement
- RHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.